“You get what you pay for” has a nice ring to it. But it does not accurately describe the situation of those buying prescription pharmaceuticals in the US. President Trump, who has vowed to lower drugs prices by as much as 80 per cent, may finally have found a useful target for his sledgehammer.
Drug prices have been a long-standing headache for successive US administrations. The complex system through which private insurers and state programmes buy pharmaceuticals means they pay a multiple of what comparable products cost in other countries.
您已閱讀19%（548字），剩餘81%（2394字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。